pandem
caus
ten
thousand
death
sever
threat
global
health
clinic
practic
demonstr
specif
antibodi
viral
antigen
use
diagnost
prognost
marker
howev
popular
pointofcar
biomark
detect
technolog
lateralflow
test
strip
provid
yesno
inform
limit
sensit
thu
high
fals
neg
rate
use
quantit
evalu
patient
immun
respons
convent
elisa
enzymelink
immunosorb
assay
hand
provid
quantit
accur
sensit
result
involv
complic
expens
instrument
long
assay
time
addit
sampl
need
sent
central
lab
significantli
increas
turnaround
time
present
microfluid
elisa
technolog
rapid
minut
quantit
sensit
detect
biomark
use
specif
igg
viral
antigen
protein
serum
also
character
variou
human
monoclon
igg
identifi
candid
high
bind
affin
toward
protein
serv
calibr
standard
igg
serolog
analys
furthermor
demonstr
microfluid
elisa
platform
use
rapid
affin
evalu
monoclon
antibodi
microfluid
elisa
devic
highli
portabl
requir
less
sampl
channel
therefor
technolog
greatli
facilit
rapid
quantit
analysi
patient
vaccin
recipi
pointofcar
certifi
peer
review
diseas
relat
novel
coronaviru
caus
ten
thousand
death
becom
sever
threat
global
health
howev
diagnosi
prognosi
still
face
seriou
challeng
current
gold
standard
method
diagnos
infect
base
detect
viral
rna
n
gene
nasal
swab
sampl
rtpcr
howev
pcrbase
diagnosi
prone
fals
neg
due
uncertainti
sampl
collect
molecular
mechan
test
unabl
track
immun
respons
viral
infect
earlier
sarscov
relat
research
recent
studi
shown
sarsspecif
antibodi
igg
igm
iga
detect
serum
earli
seven
day
viral
infect
day
symptom
appear
last
sever
year
recoveri
similar
immun
respons
also
occur
success
vaccin
day
vaccin
therefor
virusspecif
antibodi
serum
secretori
mucu
eg
saliva
sputum
use
diagnost
marker
viral
infect
evalu
patient
adapt
immun
respons
either
viru
infect
vaccin
antibodi
current
list
among
diagnost
marker
diagnosi
treatment
plan
provision
th
edit
publish
china
addit
specif
antibodi
viral
antigen
spike
protein
protein
circul
blood
use
prognosi
viremia
one
commonli
use
target
vaccin
develop
serum
concentr
protein
also
potenti
marker
earlystag
vaccin
respons
especi
subunit
vaccin
unfortun
exist
antibodi
detect
method
still
far
adequ
gold
nanoparticl
base
later
flow
assay
eg
paperbas
test
strip
popular
rapid
detect
iggigm
antibodi
especi
pointofcar
diagnost
although
fast
minut
provid
yesno
inform
limit
sensit
make
method
easi
gener
fals
positivesneg
imposs
track
patient
immun
respons
infect
treatment
vaccin
convent
elisa
enzymelink
immunosorb
assay
hand
provid
quantit
accur
sensit
result
involv
complic
expens
instrument
long
assay
time
hour
addit
sampl
need
sent
central
lab
significantli
increas
turnaround
time
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
work
present
microfluid
elisa
technolog
rapid
minut
quantit
sensit
detect
biomark
use
specif
igg
viral
antigen
protein
spike
serum
model
system
also
character
variou
human
monoclon
igg
identifi
one
high
bind
affin
toward
protein
serv
calibr
standard
igg
serolog
analys
furthermor
demonstr
microfluid
elisa
platform
use
rapid
affin
evalu
monoclon
antibodi
microfluid
elisa
devic
highli
portabl
requir
sampl
channel
easili
collect
drop
fingertip
blood
therefor
technolog
greatli
facilit
rapid
quantit
analysi
patient
vaccin
recipi
pointofcar
detail
descript
autom
elisa
system
correspond
capillari
sensor
array
found
previou
public
photo
capillari
sensor
array
found
figur
made
polystyren
use
inject
mold
method
sensor
array
channel
inner
diamet
mm
approxim
volum
act
elisa
reactor
chemiluminesc
substrat
elisa
femto
substrat
dnasernasefre
distil
water
pb
block
buffer
purchas
thermo
fisher
elisa
coat
buffer
pb
concentr
wash
buffer
concentr
reagent
diluent
bsa
pb
purchas
r
system
human
serum
purchas
millipor
sigma
humancellexpress
spike
recombin
protein
provid
sino
biolog
humancellexpress
sarscov
spike
recombin
protein
purchas
creativ
biolab
recombin
therapeut
antibodi
purchas
creativ
biolab
human
chimer
antibodi
develop
provid
sino
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
biolog
catalog
number
antipolyhistidin
antibodi
use
polyhistidinemedi
protein
immobil
see
figur
purchas
thermo
fisher
horseradish
peroxid
hrp
conjug
secondari
antibodi
use
igg
detect
experi
detect
antibodi
thermo
fisher
human
total
igg
elisa
kit
hrp
conjug
antibodi
carri
abcam
hrp
conjug
kit
molar
ratio
antibodi
hrp
illustr
reactor
prepar
protocol
elisa
protocol
found
figur
step
work
solut
wash
buffer
reagent
diluent
dilut
dnasernasefre
distil
water
achiev
work
concentr
first
step
reactor
prepar
process
figur
work
solut
captur
antibodi
ie
detect
experi
antihi
antibodi
igg
detect
antibodi
affin
experi
prepar
dilut
stock
solut
elisa
coat
buffer
pb
ph
achiev
final
concentr
note
igg
detect
antibodi
affin
experi
second
incub
step
use
block
plu
protein
immobil
protein
dissolv
bsa
protein
detect
step
use
block
bsa
pb
igg
detect
experi
see
figur
b
detail
protocol
variou
concentr
monoclon
antibodi
prepar
dilut
stock
solut
time
dilut
human
serum
serum
dilut
reagent
diluent
correl
bsa
work
solut
detect
antibodi
case
hrpconjug
secondari
antibodi
prepar
dilut
stock
solut
time
reagent
diluent
detect
experi
see
figur
c
detail
protocol
variou
concentr
protein
prepar
dilut
stock
solut
time
dilut
human
serum
work
solut
detect
antibodi
ie
hrpconjug
prepar
dilut
stock
solut
time
reagent
diluent
final
concentr
detect
antibodi
antibodi
affin
experi
variou
concentr
hrpconjug
monoclon
antibodi
prepar
dilut
stock
solut
reagent
diluent
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
signal
intens
microfluid
elisa
measur
chemiluminesc
imag
method
use
cmo
camera
see
figur
b
exampl
chemiluminesc
signal
enhanc
dynam
rang
elisa
multipl
exposur
adjust
exposur
time
appli
chemiluminesc
intens
cl
intens
normal
three
second
exposur
time
detail
explan
chemiluminesc
imag
multipl
exposur
approach
found
previou
public
receptor
bind
domain
rbd
spike
protein
locat
subunit
coronaviru
respons
bind
membran
receptor
target
cell
play
critic
role
coronaviru
cell
entri
process
patient
infect
coronaviru
hisher
immun
system
develop
antibodi
bind
block
rbd
specif
coronaviru
type
neutral
antibodi
igg
longest
lifetim
person
circul
blood
use
biomark
evalu
patient
adapt
immun
respons
degre
recoveri
addit
major
activ
ingredi
concentr
specif
igg
use
indic
strength
convalesc
plasma
reason
igg
bind
specif
protein
especi
rbd
first
biomark
aim
detect
mechan
igg
detect
illustr
figur
first
protein
immobil
capillari
inner
surfac
polyhistidin
mediat
approach
see
figur
detail
specif
igg
sampl
serum
attract
surfac
immunosorb
reaction
final
hrpconjug
detect
antibodi
use
visual
bind
immobil
igg
ensur
detect
specif
monoclon
detect
antibodi
bind
specif
fc
domain
human
igg
use
accord
protocol
figur
b
entir
assay
complet
minut
valid
feasibl
assay
select
three
recombin
human
monoclon
antibodi
posit
control
antibodi
first
antibodi
therapeut
human
igg
origin
develop
protein
sarscov
recent
report
crossreact
toward
protein
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
second
third
antibodi
human
chimer
igg
precursor
origin
rais
mous
rabbit
respect
specif
protein
sarscov
base
preliminari
result
conduct
sino
biolog
intern
also
believ
high
bind
affin
toward
protein
order
mimic
actual
clinic
situat
decid
use
time
dilut
human
serum
solvent
igg
antibodi
typic
dilut
factor
serum
actual
serolog
analys
evalu
differ
antibodi
affin
toward
sarscov
perform
sidebysid
studi
two
type
protein
three
clone
antibodi
correspond
result
shown
fig
b
gener
chemiluminesc
intens
proport
concentr
spikedin
monoclon
antibodi
three
antibodi
still
detect
ngml
type
protein
signal
type
protein
similar
indic
antibodi
bind
affin
toward
sarscov
similar
may
slightli
higher
affin
toward
sarscov
howev
signal
systemat
lower
sarscov
indic
weaker
affin
toward
sarscov
agre
recent
publish
find
bind
abil
entir
dynam
rang
three
antibodi
found
fig
linear
dynam
rang
loglog
scale
ngml
ngml
ngml
correspond
slope
linear
rang
respect
neg
control
human
igg
isotyp
gener
detect
signal
within
entir
rang
detect
ngml
due
narrow
linear
dynam
rang
rel
low
bind
affin
use
calibr
standard
igg
remain
two
antibodi
nearli
term
dynam
rang
affin
toward
howev
better
specif
compar
sarscov
therefor
may
better
candid
calibr
antibodi
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
addit
igg
protein
may
also
marker
prognosi
may
appear
blood
patient
develop
coronaviru
viremia
peopl
receiv
certain
type
coronaviru
vaccin
especi
subunit
vaccin
recent
evid
indic
viral
protein
may
also
exist
mucu
sampl
saliva
detect
protein
employ
standard
sandwich
elisa
format
illustr
fig
monoclon
rbdspecif
antibodi
use
captur
antibodi
anoth
rbdspecif
antibodi
use
detect
antibodi
reduc
number
step
well
total
assay
time
directli
conjug
hrp
molecul
detect
antibodi
accord
protocol
figur
c
entir
assay
complet
minut
igg
detect
experi
perform
sidebysid
studi
protein
sarscov
mimic
actual
clinic
set
use
time
dilut
human
serum
solvent
protein
expect
see
high
concentr
viral
protein
serum
saliva
entir
dynam
rang
detect
assay
present
fig
b
linear
dynam
rang
sarscov
ngml
ngml
slope
loglog
scale
respect
accord
figur
b
c
detect
sarscov
appear
higher
sensit
antibodi
use
assay
origin
rais
rbd
sarscov
higher
sensit
detect
protein
may
achiev
futur
antibodi
specif
develop
protein
rbd
base
studi
previou
section
obviou
good
calibr
standard
monoclon
human
human
igg
toward
protein
essenti
perform
quantit
evalu
patient
immun
respons
high
affin
antibodi
also
essenti
build
sensit
elisa
kit
howev
due
nascenc
gold
standard
antibodi
use
igg
calibr
antigen
detect
yet
consequ
urgent
find
human
antibodi
high
bind
affin
unfortun
tradit
antibodi
evalu
approach
platebas
elisa
biolay
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
interferometri
bli
surfac
plasmon
reson
spr
suffer
long
assay
time
hour
platebas
elisa
small
dynam
rang
order
magnitud
platebas
elisa
larg
sampl
concentr
consumpt
bli
spr
address
problem
present
simpl
rapid
approach
affin
assess
monoclon
antibodi
assay
mechan
correspond
protocol
illustr
figur
respect
assay
follow
singlestep
elisa
format
igg
detect
experi
recombin
protein
first
immobil
support
surfac
follow
bind
igg
reduc
potenti
sourc
error
directli
conjug
hrp
molecul
purifi
igg
molecul
molar
ratio
igg
hrp
hrp
conjug
kit
abcam
antibodi
dilut
six
differ
concentr
ngml
serial
dilut
appli
proteinco
elisa
reactor
immobil
igg
quantifi
short
minut
incub
time
rins
although
antibodi
may
reach
equilibrium
end
incub
quantiti
immobil
antibodi
also
signal
intens
still
posit
correl
affin
antibodi
compar
antibodi
affin
toward
protein
sarscov
perform
sidebysid
experi
antibodi
test
antibodi
first
three
antibodi
use
calibr
standard
igg
detect
experi
use
detect
antibodi
detect
experi
thank
simpl
protocol
assay
exhibit
excel
intraassay
consist
see
fig
exampl
thu
ensur
highli
reliabl
measur
shown
figur
b
four
antibodi
differ
affin
toward
protein
note
data
ngml
present
signal
detect
three
antibodi
except
signal
weak
see
figur
point
within
linear
dynam
rang
signal
intens
strongest
antibodi
time
higher
weakest
antibodi
exampl
signal
intens
two
antibodi
ngml
respect
hand
lowest
detect
concentr
ngml
lowest
detect
concentr
ngml
anoth
evid
differ
antibodi
affin
observ
agre
sever
recent
publish
experi
result
preliminari
result
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
measur
sino
biolog
equilibrium
dissoci
constant
kd
nm
nm
respect
base
bli
measur
contrast
shown
figur
c
antibodi
affin
toward
sarscov
differ
exampl
bind
affin
toward
sarscov
stronger
affin
toward
convers
bind
affin
toward
sarscov
weaker
addit
pattern
calibr
curv
significantli
differ
sarscov
affin
toward
vari
significantli
appear
similar
toward
sarscov
although
current
method
allow
us
rapidli
evalu
rel
affin
among
antibodi
unabl
extract
exact
valu
kd
problem
resolv
introduc
multipl
calibr
antibodi
known
affin
demonstr
portabl
chemiluminesc
microfluid
elisa
system
abl
conduct
sensit
detect
quantif
biomark
minut
use
microlit
size
sampl
volum
llod
ngml
igg
serum
achiev
use
human
chimer
antibodi
model
system
also
success
character
differ
antibodi
identifi
antibodi
candid
use
calibr
antibodi
quantit
evalu
igg
approach
also
extend
evalu
therapeut
convalesc
plasma
furthermor
demonstr
sensit
detect
protein
antigen
llod
ngml
final
show
technolog
use
altern
approach
rapid
minut
screen
valid
monoclon
antibodi
method
requir
ten
nanogram
sever
order
magnitud
smaller
use
tradit
labelfre
method
bli
spr
use
screen
select
high
affin
therapeut
neutral
antibodi
researchus
antibodi
continu
optim
assay
multipl
aspect
igg
detect
investig
human
patientderiv
antibodi
identifi
optim
calibr
high
bind
affin
larg
linear
dynam
rang
differ
antibodi
affin
monomer
commonli
use
antibodi
vaccin
develop
trimer
natur
conform
viru
also
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
explor
protein
detect
improv
detect
sensit
sinc
abund
may
low
actual
patient
sampl
base
previou
public
llod
greatli
enhanc
replac
hrpconjug
detect
antibodi
biotinyl
detect
antibodi
becom
avail
antibodi
affin
evalu
aim
optim
assay
protocol
adjust
incub
time
rins
time
employ
evalu
therapeut
research
use
antibodi
approach
also
open
door
relat
clinic
laboratori
research
exampl
diagnost
valu
relat
biomark
serum
saliva
especi
specif
iga
igm
viral
antigen
nucleocapsid
n
protein
current
intens
evalu
igg
detect
method
describ
work
easili
adapt
detect
quantifi
type
antibodi
igm
iga
concept
protein
detect
also
adapt
detect
type
viral
antigen
n
protein
describ
figur
direct
detect
viral
antigen
patient
sampl
serum
saliva
may
facilit
rapid
costeffect
diagnosi
final
microfluid
elisa
platform
use
studi
neutral
efficaci
therapeut
antibodi
see
figur
well
recognit
evalu
phenotyp
natur
recombin
fake
viral
particl
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
figur
detect
igg
illustr
assay
mechan
sampletoansw
time
assay
minut
b
detect
specif
igg
time
dilut
serum
protein
red
squar
sarscov
black
circl
calibr
curv
gener
three
differ
monoclon
human
antibodi
b
c
solid
line
linear
fit
data
loglog
scale
error
bar
gener
duplic
measur
see
also
figur
entir
dynam
rang
respect
lower
limit
detect
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
figur
protein
detect
illustr
assay
mechan
sampletoansw
time
assay
minut
b
entir
dynam
rang
protein
red
squar
sarscov
protein
black
circl
time
dilut
human
serum
averag
background
subtract
data
point
solid
line
linear
fit
data
loglog
scale
grey
shade
area
mark
deviat
background
lower
limit
detect
llod
protein
sarscov
ngml
ngml
respect
c
calibr
curv
protein
ngml
error
bar
gener
duplic
measur
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
differ
monoclon
human
specif
igg
protein
b
sarscov
c
solid
line
linear
fit
data
loglog
scale
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
